HD-OPM Archive
Topics › Hormones, women's & men's health

JAMA editorial backs deprescribing levothyroxine for subclinical hypothyroidism in elders

Louis Nervegna · Apr 06, 2026 · ♥ 5 reactions · 11 comments · original Facebook post
Hormones, women's & men's health
AI summary & key facts

Louis shares a JAMA editorial arguing that continued levothyroxine without clear benefit in older adults likely does more harm than good, recommending repeat TSH testing and gradual dose reduction. Not heart-specific.

Recent evidence suggests continuing to treat patients with levothyroxine for “subclinical hypothyroidism” when they experience no obvious clinical benefit, likely causes more harm than good.

#hypothyroidismHD #levothyroxineHD

Research cited

Shared from JAMA · original post

💬 Editorial: Recent evidence supports deprescribing low-dose levothyroxine in older adults without clear indication, especially for those with subclinical #Hypothyroidism.

Repeating thyrotropin testing before prescribing and following gradual dose reduction protocols can reduce inappropriate therapy and iatrogenic risks.

Consensus on treatment thresholds and clearer guidance on levothyroxine initiation and discontinuation are needed to help clinicians navigate complexities in thyroid hormone management for older adults.

Paper · JAMA · 2026Navigating Thyroid Hormone Deprescribing in Older Adultsjamanetwork.comNo photo description available.
← newer: Raising HDL/ApoA-I has failed in every major outcome trial, older: Glycine 5 g three times daily lowered A1C from 8.3 to 6.9 in →